It’s been more than four years since Novartis shook up the CAR-T space with its T-Charge platform. But that’s a lifetime in ...

(Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in cash, as the company looks to bolster its portfolio of treatments ...

A Novartis cross-border partnership is turning into a standoff. | A Novartis cross-border partnership is turning into a ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

AbbVie's 85 layoffs are tied to its Allergan Aesthetics headquarters in California, while Novartis is cutting more staff at ...

After a series of staff consolidation moves in recent weeks, Novartis is again trimming its ranks, albeit in what appears to ...

Loomis Sayles, an investment management company, released its “Global Growth Fund” investor letter for the first quarter of ...

Novartis' CEO warned Tuesday that U.S. drug pricing policy under President Donald Trump poses a "very difficult situation." ...

Novartis is advancing early-stage research and clinical trials in India, reinforcing its commitment to innovative medicines ...

Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and ...

Novartis is doubling down on the Triangle. The drug giant announced Thursday that it will build a 56,200-square-foot active ...

The pharmaceutical organization will produce drugs for radioligand therapy, a form of targeted radiation used to treat advanced forms of cancer.